-
de Bruijne,E.L., Darwish Murad,S., de Maat,M.P., Tanck,M.W., Haagsma,E.B., van Hoek,B., Rosendaal,F.R., Janssen,H.L. and Leebeek,F.W.
Genetic variation in thrombin-activatable fibrinolysis inhibitor (TAFI) is associated with the risk of splanchnic vein thrombosis
Thromb Haemost97, 181-185. PubMed Europe PubMed DOI M
2007
